Form 10-Q

Movano Inc. to Report Third Quarter 2023 Financial Results on Wednesday, November 15, 2023

Retrieved on: 
Tuesday, November 14, 2023
EST, Medtech, Form 10-Q, Evie, Pharmaceutical industry

PLEASANTON, Calif., Nov. 14, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that, in light of the Company's recently announced proposed common stock offering, Movano Health has issued its Form 10-Q for the third quarter of 2023 and will report third quarter 2023 financial and operating results on Wednesday, November 15, 2023, before the equity markets open. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 8:30 a.m. PST (11:30 a.m. EST).  

Key Points: 
  • Management will host a conference call and live audio webcast to discuss these results and provide a business update at 8:30 a.m. PST (11:30 a.m. EST).
  • Attendees can access the live webcast here or on the investors section of Movano Health's website at https://ir.movano.com .
  • The conference call can be accessed by dialing 1-877-407-0989 (domestic) or +1- 201-389-0921 (international).
  • An archived webcast will be available on Movano Health's website approximately one hour after the completion of the event and for two years thereafter.

Enerflex Ltd. Reports Third Quarter 2023 Financial and Operational Results

Retrieved on: 
Wednesday, November 8, 2023
Management, Risk, PP&E, US, Public expenditure, Proxy, EDGAR, EBITDA, News, Form 10-Q, Acquisition, Maintenance, Transaction, Growth, Prospectus, Form 10-K, Energy, Pandemic, PP, Natural gas, Security (finance), Enerflex, Exterran Corporation

CALGARY, Alberta, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) today reported its financial and operational results for the three and nine months ended September 30, 2023. All amounts are presented in Canadian dollars unless otherwise stated.

Key Points: 
  • These adjustments and Enerflex's bank-adjusted net debt to EBITDA ratio are calculated in accordance with, and derived from, the Company's financing agreements.
  • These statements relate to Management's expectations about future events, results of operations, the future performance (both financial and operational) and business prospects of Enerflex, and other matters that may occur in the future.
  • Actual results may vary from the prospective financial information set forth in this news release.
  • The prospective financial information set forth in this news release should not be relied on as necessarily indicative of future results.

Infinera Corporation Announces Preliminary Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, November 8, 2023
Form 10-Q, System, Documentation, EY, Infinera, Disclosure, GAAP, Late, Interest, Public Company Accounting Oversight Board, EPS, SSP, Form 10-K, Ernst & Young, INFN, SAN, Casino, Reinsurance, Bookkeeping

SAN JOSE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) (or “Company”) today released preliminary financial results for its third quarter ended September 30, 2023.

Key Points: 
  • SAN JOSE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) (or “Company”) today released preliminary financial results for its third quarter ended September 30, 2023.
  • Infinera CEO David Heard said, “The third quarter was another solid quarter for us, with all key preliminary financial metrics – revenue, gross margin, operating margin, and EPS, expected to be ahead of the midpoint of our outlook range.
  • Once the review process with EY is complete, the Company will report full financial results for the third quarter of 2023.
  • Infinera will host a conference call for analysts and investors to discuss its preliminary results for the third quarter of 2023 and its preliminary outlook for the fourth quarter of 2023 today at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Agrify Receives Extended Stay of Suspension from Nasdaq

Retrieved on: 
Wednesday, November 8, 2023
Security (finance), Sumathi Best Television Current Reporting Award, Listing Rules, Bank statement, Listing, Form 10-Q, Panel, Delinquent, Annual report, Hearing, Calendar, Letter, Audit

TROY, Mich., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) (“Agrify”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that on November 6, 2023 it received a letter from the Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying Agrify that the stay of suspension for Agrify’s common stock will be extended until a hearing before the Panel and issuance of a final Panel decision.

Key Points: 
  • TROY, Mich., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) (“Agrify”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that on November 6, 2023 it received a letter from the Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying Agrify that the stay of suspension for Agrify’s common stock will be extended until a hearing before the Panel and issuance of a final Panel decision.
  • The Staff Determination had no immediate effect and will not immediately result in the suspension of trading or delisting of Agrify’s shares of common stock.
  • Agrify filed amended Forms 10-Q on October 2, 2023 with the required restated financial statements.
  • There can be no assurance that Agrify will be able to file the Delinquent Reports within the extension period granted by the Panel.

Cutera Provides Third Quarter 2023 Business Update

Retrieved on: 
Wednesday, November 8, 2023
General Health, Health, Medical Devices, Consolidated, Form 10-Q, Dermatology, Software, Growth, Communication, Video game, Pharmaceutical industry

Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today provided preliminary financial results for the third quarter ended September 30, 2023, as well as recent business updates.

Key Points: 
  • Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today provided preliminary financial results for the third quarter ended September 30, 2023, as well as recent business updates.
  • In connection with the restructuring, Cutera expects to incur approximately $2 million in one-time expenses, primarily in the fourth quarter.
  • At CUCF this past weekend, Cutera introduced an enhanced AviClear offering, which provides greater flexibility, reliability and support for this innovative, first-to-market technology.
  • The Company expects full-year 2023 revenue of approximately $205 million and ending 2023 cash and marketable securities of approximately $135 million.

Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results

Retrieved on: 
Tuesday, November 7, 2023
Standard BioTools, Hyperion, Genomics, Security (finance), Terrorism, Vii, 600 (number), Supplement, Xi, Health, SBI, Appendix, EBITDA, SomaLogic, News, Form 10-Q, GAAP, Intellectual property, Doctor of Philosophy, Original equipment manufacturer, Research, COVID-19, Risk, Marketing, Annual report, Webcast, Form 10-K, Mass cytometry, Depreciation, Egholm, Standard, Total, Table, Investment, XV, Microfluidics, Hart–Scott–Rodino Antitrust Improvements Act, Failure, Reverse transcription polymerase chain reaction, Fine chemical, Bank, Mergers and acquisitions

As previously announced on October 4, 2023, the Company expects total revenue of $100 million to $105 million for the full year 2023.

Key Points: 
  • As previously announced on October 4, 2023, the Company expects total revenue of $100 million to $105 million for the full year 2023.
  • An explanation of these non-GAAP financial measures is also included below under the heading “Use of Non-GAAP Financial Information.
  • ET, to discuss third quarter 2023 financial results and operational progress as well as to provide additional color on its strategic actions.
  • Standard BioTools has presented certain financial information in accordance with U.S. GAAP and also on a non-GAAP basis.

Gatos Silver Reports Third Quarter 2023 Financial Results and Increases 2023 Production Guidance

Retrieved on: 
Monday, November 6, 2023
Line of credit, NYSE, Silver, EDGAR, Form, CLG, Form 10-Q, Cost, AISC, Cryptocurrency, Palladium, Bank

VANCOUVER, British Columbia, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Gatos Silver, Inc. (NYSE/TSX: GATO) (“Gatos Silver” or the “Company”) today announced its third quarter 2023 financial and operating results.

Key Points: 
  • VANCOUVER, British Columbia, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Gatos Silver, Inc. (NYSE/TSX: GATO) (“Gatos Silver” or the “Company”) today announced its third quarter 2023 financial and operating results.
  • Production for the third quarter of 2023 was previously disclosed on October 10, 2023.
  • Dale Andres, CEO of Gatos Silver, said: “The LGJV continues to generate robust cash flows with the CLG mine consistently producing high margin silver ounces.
  • Below is select operational and financial information for the three and nine months ended September 30, 2023 and 2022.

Prospect Capital Schedules First Fiscal Quarter Earnings Release and Conference Call

Retrieved on: 
Monday, November 6, 2023
PSEC, China International Capital Corporation, Security (finance), Form 10-Q, Exchange, Cryptocurrency

The Company also expects to issue its earnings press release on Wednesday, November 8, 2023 after the close of the markets.

Key Points: 
  • The Company also expects to issue its earnings press release on Wednesday, November 8, 2023 after the close of the markets.
  • The Company will host a conference call on Thursday, November 9, 2023 at 10:30 a.m. Eastern Time.
  • The conference call will also be available via a live listen-only webcast on the Company’s website, www.prospectstreet.com .
  • A replay of the audio webcast will be available on the Company's website for approximately 30 days following the conference call.

Barfresh Regains Compliance With Nasdaq Stockholders Equity Requirement

Retrieved on: 
Wednesday, November 1, 2023
Rule, Growth, Form, Form 10-Q, Letter, Rare-earth element

LOS ANGELES, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Barfresh Food Group Inc. (the “Company”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, today announced that it has received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), informing the Company that it has regained compliance with the minimum stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b)(1).

Key Points: 
  • LOS ANGELES, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Barfresh Food Group Inc. (the “Company”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, today announced that it has received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), informing the Company that it has regained compliance with the minimum stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b)(1).
  • As previously announced, the Company was notified by Nasdaq on May 3, 2023 that it was not in compliance with the minimum stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b)(1).
  • On June 14, 2023, the Company received a letter from Nasdaq granting the Company an extension through October 30, 2023 to regain compliance with the Rule.
  • The proceeds from the convertible notes increased stockholders’ equity to meet the requirement and were not required to support the growth of the company.

Alexander’s Announces Third Quarter Financial Results

Retrieved on: 
Monday, October 30, 2023
Sale, Risk, Form 10-Q, FFO, ALX, Rego Park, Queens, Annual report, New York Stock Exchange, Cryptocurrency

PARAMUS, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) -- ALEXANDER’S, INC. (New York Stock Exchange: ALX) filed its Form 10-Q for the quarter ended September 30, 2023 today and reported:

Key Points: 
  • PARAMUS, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) -- ALEXANDER’S, INC. (New York Stock Exchange: ALX) filed its Form 10-Q for the quarter ended September 30, 2023 today and reported:
    Net income for the quarter ended September 30, 2023 was $10.8 million, or $2.10 per diluted share, compared to $15.1 million, or $2.95 per diluted share for the quarter ended September 30, 2022.
  • Funds from operations (“FFO”) (non-GAAP) for the quarter ended September 30, 2023 was $18.6 million, or $3.63 per diluted share, compared to $22.5 million, or $4.40 per diluted share for the quarter ended September 30, 2022.
  • Nine Months Ended September 30, 2023 Financial Results
    Net income for the nine months ended September 30, 2023 was $86.1 million, or $16.79 per diluted share, compared to $44.5 million, or $8.67 per diluted share for the nine months ended September 30, 2022.
  • Below is a table of selected financial results.